Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2

J Gyuris1, E Golemis, H Chertkov

  • 1Department of Molecular Biology, Massachusetts General Hospital, Boston 02114.

Cell
|November 19, 1993
PubMed

Insights

We discovered cyclin-dependent kinase interactor 1 (Cdi1), a novel protein phosphatase that interacts with cyclin-dependent kinases. Cdi1

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Enzymology

Background:

  • Cyclin-dependent kinases (CDKs) are crucial regulators of the cell cycle.
  • Understanding CDK interactors is key to deciphering cell cycle control mechanisms.

Purpose of the Study:

  • To identify novel human proteins that interact with cyclin-dependent kinases.
  • To characterize the function and enzymatic activity of a newly identified CDK interactor.

Main Methods:

  • Utilized the yeast interaction trap, a genetic selection system, to isolate interacting proteins.
  • Performed biochemical assays to determine phosphatase activity and substrate specificity.
  • Investigated protein complex formation in human (HeLa) cells.
  • Conducted cell cycle progression studies in yeast and HeLa cells.

Main Results:

  • Identified human cyclin-dependent kinase interactor 1 (Cdi1) using the interaction trap.
  • Cdi1 interacts with several human CDKs (Cdc2, Cdk2, Cdk3) in yeast.
  • Cdi1 exhibits tyrosine phosphatase activity in vitro, confirmed by a catalytically inactive mutant.
  • Cdi1 forms stable complexes with Cdk2 in HeLa cells and is expressed during the G1 to S transition.
  • Overexpression of Cdi1 delays cell cycle progression in both yeast and HeLa cells, dependent on its phosphatase activity.

Conclusions:

  • Cdi1 is a novel protein phosphatase that complexes with cyclin-dependent kinases.
  • Cdi1's phosphatase activity plays a role in regulating cell cycle progression.
  • This discovery provides new insights into the intricate network of cell cycle control.

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...